Archive · 26 Jun 2025

India's Pharma Innovation Faces Funding Hurdles, Says DCGI

India's Pharma Innovation Faces Funding Hurdles, Says DCGI

At a healthcare summit, India's drug controller said that there isn't enough money to fund new medicine ideas in India.

He wants companies to find international investors to help.

The government is also making it easier to follow the rules.

India, known for making generic medicines, needs to start focusing on creating new and valuable medicines, not just copies of existing ones.

Companies like Dr. Reddy's are trying to sell more than just generic medicines.

They are starting new partnerships and buying other businesses to expand their products, like vitamins and medicines to help people quit smoking.

Doctors also emphasized the increasing health issues such as cancer and diabetes.

Sources